‘Electrosurgical Energy Devices Market Worth Over $3.6 Billion In 2017’ Says Visiongain Report

23 August 2017
Pharma

Visiongain’s new report The Global Electrosurgical Energy Devices Market Forecast, 2017-2027: Revenue Prospects by Product (Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems), Application (General, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic and Neurosurgery) and Geography indicates that the Electrosurgical Energy Devices market will see over $3.6bn in revenue in 2017.
The lead analyst of the report said:

“The market for electrosurgical energy devices is driven by the increase in geriatric population, increased demand for technologically advanced procedures, an increase in minimally invasive procedures, and the general increase in the number of surgical procedures worldwide. However, certain factors such as stringent government regulation are expected to restrain the market during the forecast period.

The electrosurgical energy devices market is also driven by top players such as Medtronic Plc, Johnson and Johnson, Olympus Corporation and Others. The key strategies adopted by the key players in this industry includes product approval, launch, & enhancement; acquisitions & mergers; agreements & collaborations; and expansion. Product approval, launch, & enhancement was the most commonly adopted strategy by the leading players in electrosurgical devices market in the period of January 2014-November 2016.”

The 157-page report contains 170 tables, charts and graphs that add visual analysis in order to explain developing trends within the Electrosurgical Energy Devices. Visiongain provides revenue forecasts for the period 2017-2027 for the leading Electrosurgical Energy Device submarkets, segmented by product, with forecasts for Electrosurgical Generators, Instruments, Accessories and Argon and Smoke Management Systems. Included in the Electrosurgical Instruments segment are forecasts for Bipolar Instruments (including forecasts for Advanced Vessel Sealing Instruments and Bipolar Forceps) and Monopolar Instruments (including forecasts for Patient Return Electrodes, Cords, Cables and Adapters and Others) The market is also segmented by application, and includes forecasts for General Surgery, Gynaecologic Surgery, Urologic Surgery, Orthopaedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery and Others.

The 157-page report offers market forecasts and analysis for 19 national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the field in Electrosurgical Energy Device technology in detail.

The Global Electrosurgical Energy Devices Market Forecast, 2017-2027: Revenue Prospects by Product (Electrosurgical Generators, Instruments and Accessories, Argon and Smoke Management Systems), Application (General, Gynaecologic, Urologic, Orthopaedic, Cardiovascular, Cosmetic and Neurosurgery) and Geography report will be of value to anyone who wants to better understand the electrosurgical energy device market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the electrosurgical energy device industry.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Generic Drugs market set to grow to $424bn by 2024” says new Visiongain report

Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.

14 June 2019

Read

“Global Precision Cancer Diagnostic Tests market set to grow to $21.3bn by 2024” says new Visiongain report

The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.

06 June 2019

Read

“Global Antifungal Drugs market set to grow to $17bn by 2024” says new Visiongain report

Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.

04 June 2019

Read

“Global Ophthalmic Equipment market set to grow to $75bn by 2024” says new Visiongain report

here is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world.

03 June 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever